Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.

Pharmaceutical

Orca Bio

Ivan Dimov

Head Of Legal

James Scott McClellan

Virginia Sullivan

Tamas Blandl

Sanford Ng

Kelsey Grossman

Ethan Galloway

Dan Kirby

Josh Murray

Scott Mcclellan

Colm Hunt

Nate Fernhoff

Jeroen Bekaert

Clinical and Regulatory Operations

Engineering and Technical Development

Leadership Team

Teams at Orca Bio

Clinical and Regulatory Operations

Engineering and Technical Development

Leadership Team